• Contact quintiles

    Phone:+1 866 267 4479

    Request a Proposal

  • Therapeutic Expertise Oncology

  • clinical-trials-header
  • Quintiles Clinical Trial

    To develop and launch new cancer therapies, you need a collaborative partner that understands your specific challenges and the broader oncology landscape. From molecular pathways, biomarker identification and early phase trials to regulatory submission and product launch, Quintiles can help you across the lifecycle, from designing your trials and finding the right patients, to gaining regulatory approval and accelerating market adoption.

    With services spanning Phase I to commercialization, we helped develop or commercialize all of the 45 top-selling oncology drugs of 2012. How can we help you achieve real results for your oncology program? With experience in virtually all major cancer indications, we integrate deep scientific and therapeutic insights to help optimize your development strategy. Combining that with our unmatched operational expertise, we can extend the capabilities of your oncology teams across the product lifecycle – and across the globe. The result: Increased probability of gathering the right data to support product utility, regulatory approval and commercial uptake.

    What can drive your oncology compound’s success? Trust Quintiles’ breadth and depth of experience:

    • Translational Oncology – From genomic analysis to biomarker assessment, we’re equipped with the latest scientific advances to help you determine compound biology as well as identify and validate biomarkers.
    • Early Phase Oncology – Get to proof of concept more efficiently and gain early insights to help you make smarter, more targeted decisions about your compound faster. Our track record: more than 450 Phase I/II oncology studies worldwide from 2007 to 2012.
    • Site Strategy & Patient Recruitment – Our holistic approach to identifying the right sites and patients helps streamline trial start up and accelerate timelines. One key to our success: Our global network of 500 partner sites and 2,300 oncology investigators.
    • Go-to-Market Strategy – Our global oncology commercial teams include sales, clinical educators and medical science liaisons to maximize market access for optimal pricing and reimbursement.
    • Genomic Know-How – EA|Quintiles provides whole genome to focused set gene expression profiling and genotyping assays along with DNA and RNA sequencing services, sequence enrichment technologies and bioinformatics support.
    • Oncology Center of Excellence – This virtual, cross-functional team of therapeutic experts integrate their specialized knowledge with data-driven insights to help optimize your development strategy for your product, program or portfolio.

  • More expertise in oncology therapies than any other CRO

  • Quintiles Clinical Trails

    Setting the right course early in oncology development is critical.  In a webcast archive, leading oncology experts  provide insights into the current R&D challenges in oncology and key success criteria for Phase I oncology studies.  Download the webcast

  • Quintiles Clinical Trails

    Whether you’re a small biotechnology firm or a large pharmaceutical company, Quintiles offers the right strategic and operational approach to meet your goals. View our Fact Sheet